Newswise Feature Channel: Liver Disease /articles/channels/Liver Disease This [feature]/[breaking news]/[focus] channel highlights experts, research, and feature stories related to... en-us Copyright 2025 Newswise Newswise Feature Channel: Liver Disease 115 31 / /images/newswise-logo-rss.gif Diesel Exhaust Exposure Led to Disarray in Liver Function in Mice /articles/diesel-exhaust-exposure-led-to-disarray-in-liver-function-in-mice/?sc=c6487 /articles/diesel-exhaust-exposure-led-to-disarray-in-liver-function-in-mice/?sc=c6487 Tue, 04 Mar 2025 11:00:46 EST Cancer,Cardiovascular Health,Diabetes,Healthcare,Liver Disease Medical News Research Alert University of California, Los Angeles (UCLA), Health Sciences STIM1: The Cancer Shield Against Sorafenib Unmasked /articles/stim1-the-cancer-shield-against-sorafenib-unmasked/?sc=c6487 /articles/stim1-the-cancer-shield-against-sorafenib-unmasked/?sc=c6487 Tue, 04 Mar 2025 08:20:58 EST All Journal News,Biotech,Cancer,Healthcare,Healthspan,Liver Disease,Personalized Medicine Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2025/03/04/67c6f001e8c71_1.jpg&width=100&height=150" alt="Newswise image" />A recent study unveils how stromal interaction molecule 1 (STIM1), a protein involved in calcium signaling, plays a pivotal role in the resistance of liver cancer to sorafenib, a key treatment for advanced hepatocellular carcinoma (HCC). /articles//images/uploads/2025/03/04/67c6f001e8c71_1.jpg Chinese Academy of Sciences Metabolic Shift in Liver Cancer: How PDHX Acetylation Drives Tumor Growth /articles/metabolic-shift-in-liver-cancer-how-pdhx-acetylation-drives-tumor-growth/?sc=c6487 /articles/metabolic-shift-in-liver-cancer-how-pdhx-acetylation-drives-tumor-growth/?sc=c6487 Mon, 03 Mar 2025 05:50:37 EST All Journal News,Cancer,Cell Biology,Genetics,Liver Disease,Technology Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2025/03/03/67c56c468cc8e_1.jpg&width=100&height=150" alt="Newswise image" />A recent study has unveiled a new mechanism driving hepatocellular carcinoma (HCC) progression through the acetylation of pyruvate dehydrogenase complex (PDC) component X (PDHX), a critical component of the PDC. This modification disrupts PDC assembly, inhibits its function, and shifts metabolism towards aerobic glycolysis, promoting tumor growth. The findings highlight PDHX acetylation as both a potential biomarker and therapeutic target, offering new possibilities for liver cancer treatment and advancing our understanding of cancer cell metabolism. /articles//images/uploads/2025/03/03/67c56c468cc8e_1.jpg Chinese Academy of Sciences Cedars-Sinai Sets New Record in Organ Transplantation /articles/cedars-sinai-sets-new-record-in-organ-transplantation/?sc=c6487 /articles/cedars-sinai-sets-new-record-in-organ-transplantation/?sc=c6487 Fri, 28 Feb 2025 18:45:11 EST Heart Disease,Liver Disease,Patient Safety,Respiratory Diseases and Disorders,Surgery,Transplantation,Top Hit Stories Medical News Announcement <img src="/legacy/image.php?image=https://content.presspage.com/uploads/2110/6aba4cc5-8c2e-4015-92fa-3745230087a5/1920_surgery01.jpg?10000&width=100&height=150" alt="Newswise image" />The Cedars-Sinai Comprehensive Transplant Center and the Smidt Heart Institute set a new record in 2024 by completing 682 solid organ transplants--the most the medical center has performed in a year--as patient survival outcomes continued to meet or exceed the national average. /articles/https://content.presspage.com/uploads/2110/6aba4cc5-8c2e-4015-92fa-3745230087a5/1920_surgery01.jpg?10000,https://content.presspage.com/uploads/2110/3d3d05c7-3f6b-49cb-820b-f17c5f1faae5/800_irenekimmd-transplantsurgeon-directorofcomprehensivetransplantcenter.jpg?x=1740005022467 Cedars-Sinai Artificial Intelligence Helps Find Undiagnosed Liver Disease /articles/artificial-intelligence-helps-find-undiagnosed-liver-disease/?sc=c6487 /articles/artificial-intelligence-helps-find-undiagnosed-liver-disease/?sc=c6487 Thu, 27 Feb 2025 19:10:40 EST All Journal News,Artificial Intelligence,Cardiovascular Health,Healthcare,Heart Disease,Liver Disease,NEJM,Top Hit Stories Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2025/02/27/67c0a2d13a543_1920echocardiogram-ai-cedars-sinai02-27-25.jpg&width=100&height=150" alt="Newswise image" />An artificial intelligence (AI) program can identify chronic liver disease from videos taken during a common heart test known as an echocardiogram, Cedars-Sinai investigators report. /articles//images/uploads/2025/02/27/67c0a2d13a543_1920echocardiogram-ai-cedars-sinai02-27-25.jpg,/images/uploads/2025/02/27/67c0a2f7e41e1_AlanKwanMD.jpg,/images/uploads/2025/02/27/67c0a31b52d9d_DavidOuyangMD.jpg,/images/uploads/2025/02/27/67c0a34f0239a_SumeetChughMD.jpg Cedars-Sinai How Solving a Hepatitis B Paradox Opened the Door to New Therapies /articles/how-solving-a-hepatitis-b-paradox-opened-the-door-to-new-therapies/?sc=c6487 /articles/how-solving-a-hepatitis-b-paradox-opened-the-door-to-new-therapies/?sc=c6487 Thu, 27 Feb 2025 16:50:21 EST All Journal News,Healthcare,Infectious Diseases,Liver Disease,Public Health,Cell (journal) Medical News Research Alert Rockefeller University Procedimiento doble combina trasplante de higado y cirugia bariatrica /articles/procedimiento-doble-combina-trasplante-de-h-gado-y-cirug-a-bari-trica/?sc=c6487 /articles/procedimiento-doble-combina-trasplante-de-h-gado-y-cirug-a-bari-trica/?sc=c6487 Thu, 27 Feb 2025 11:10:02 EST Liver Disease,Surgery,Transplantation Medical News Feature Cirujanos de Mayo Clinic descubrieron que un enfoque innovador puede ayudar a los pacientes con obesidad a recibir atencion vital. La obesidad puede ser una barrera para el transplante de higado. La Dra. Julie Heimbach, directora del Centro de Trasplantes de Mayo Clinic en Rochester, Minnesota, afirma que la combinacion de la cirugia de manga gastrica, un tipo de cirugia bariatrica, con el trasplante de higado, es eficaz para hacer frente a ambos problemas de salud. Mayo Clinic Induced pluripotent stem cell-derived mesenchymal stem cells for modeling and treating metabolic associated fatty liver disease and metabolic associated steatohepatitis: Challenges and opportunities /articles/induced-pluripotent-stem-cell-derived-mesenchymal-stem-cells-for-modeling-and-treating-metabolic-associated-fatty-liver-disease-and-metabolic-associated-steatohepatitis-challenges-and-opportunities/?sc=c6487 /articles/induced-pluripotent-stem-cell-derived-mesenchymal-stem-cells-for-modeling-and-treating-metabolic-associated-fatty-liver-disease-and-metabolic-associated-steatohepatitis-challenges-and-opportunities/?sc=c6487 Wed, 26 Feb 2025 12:00:34 EST Stem Cells,Biotech,All Journal News,Liver Disease Medical News Research Alert The potential of induced pluripotent stem cells (iPSCs) for modeling and treating metabolic associated fatty liver disease (MAFLD) and metabolic associated steatohepatitis (MASH) is emerging. MAFLD is a growing global health concern, curren World Journal of Stem Cells Yale Gynecology Chair: Endometriosis-Associated microRNAs Impact Liver Metabolism /articles/yale-gynecology-chair-endometriosis-associated-micrornas-impact-liver-metabolism/?sc=c6487 /articles/yale-gynecology-chair-endometriosis-associated-micrornas-impact-liver-metabolism/?sc=c6487 Mon, 24 Feb 2025 18:55:29 EST Healthcare,Liver Disease,OBGYN,Women's Health Medical News Feature Expert <img src="/legacy/image.php?image=/images/uploads/2025/02/24/67bcb4d4173e3_7371087c-77fc-417f-a9e2-649d2c5f85f3.jpeg&width=100&height=150" alt="Newswise image" /> /articles//images/uploads/2025/02/24/67bcb4d4173e3_7371087c-77fc-417f-a9e2-649d2c5f85f3.jpeg Yale School of Medicine Study: Endometriosis-Linked microRNAs Help Regulate Liver Metabolism /articles/study-endometriosis-linked-micrornas-help-regulate-liver-metabolism/?sc=c6487 /articles/study-endometriosis-linked-micrornas-help-regulate-liver-metabolism/?sc=c6487 Mon, 24 Feb 2025 17:40:57 EST All Journal News,Healthcare,Liver Disease,OBGYN,Women's Health Medical News Research Alert Yale School of Medicine 'Deaths of Despair' More than Double in the U.S. Over Two Decades /articles/deaths-of-despair-more-than-double-in-the-u-s-over-two-decades/?sc=c6487 /articles/deaths-of-despair-more-than-double-in-the-u-s-over-two-decades/?sc=c6487 Thu, 20 Feb 2025 08:30:31 EST Alcohol and Alcoholism,All Journal News,Behavioral Science,Drugs and Drug Abuse,Healthcare,Liver Disease,Mental Health,Public Health,Top Hit Stories Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2025/02/19/67b64557b0ba4_deaths-of-despair-graph.jpg&width=100&height=150" alt="Newswise image" />A study finds a troubling rise in 'deaths of despair' in the U.S. from 1999 to 2021, using the International Classification of Diseases. These deaths, defined by 19 underlying causes such as chronic hepatitis, liver cirrhosis, suicide, drug overdoses, and alcohol-related conditions, increased two-and-a-half-fold over two decades. By 2021, deaths of despair would have become the fifth leading cause of death in the U.S., surpassing 176,000 fatalities, and ranking just behind heart disease, cancer, COVID-19 and accidents. /articles//images/uploads/2025/02/19/67b64557b0ba4_deaths-of-despair-graph.jpg,/images/uploads/2025/02/19/67b645697328b_deaths-of-despair.jpg Florida Atlantic University How Livers Regenerate and Why That Matters /articles/how-livers-regenerate-and-why-that-matters/?sc=c6487 /articles/how-livers-regenerate-and-why-that-matters/?sc=c6487 Fri, 14 Feb 2025 09:35:47 EST Children's Health,Healthcare,Liver Disease,Transplantation Medical News Blog The liver is an underappreciated, but dependable organ with superhero-like powers. Children's Hospital Los Angeles Semaglutide Shows Promise in Reducing Cravings for Alcohol, Heavy Drinking /articles/semaglutide-shows-promise-in-reducing-cravings-for-alcohol-heavy-drinking/?sc=c6487 /articles/semaglutide-shows-promise-in-reducing-cravings-for-alcohol-heavy-drinking/?sc=c6487 Wed, 12 Feb 2025 19:35:54 EST Alcohol and Alcoholism,All Journal News,Clinical Trials,Diabetes,Healthcare,Kidney Disease,Liver Disease,Obesity,JAMA,Top Clipped Stories Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2025/02/12/67accf95b2e2d_KleinKlara490-5905.jpg&width=100&height=150" alt="Newswise image" />Randomized, placebo-controlled trial finds that low-dose semaglutide reduces amount of alcohol consumption, alcohol cravings, and heavy drinking days. Reductions in cigarettes per day were also seen. /articles//images/uploads/2025/02/12/67accf95b2e2d_KleinKlara490-5905.jpg,/images/uploads/2025/02/12/67acd1b156f5a_ChristianHendershot.png University of North Carolina School of Medicine The Latest Developments on Cancer Research and Liver Transplantation Outcomes Are Among the Topics to Be Highlighted at the Annual Academic Surgical Congress /articles/the-latest-developments-on-cancer-research-and-liver-transplantation-outcomes-are-among-the-topics-to-be-highlighted-at-the-annual-academic-surgical-congress/?sc=c6487 /articles/the-latest-developments-on-cancer-research-and-liver-transplantation-outcomes-are-among-the-topics-to-be-highlighted-at-the-annual-academic-surgical-congress/?sc=c6487 Mon, 10 Feb 2025 20:35:49 EST Healthcare,Liver Disease,Robotics,Surgery,Transplantation,Medical Meetings Medical News Research Results The latest developments in breast lesion detection, robotic cancer resection, liver transplantation, and pancreatic cancer tumor detection are some of the topics to be covered by UCLA doctors and scientists at the 20th annual Academic Surgical Congress (ASC). University of California, Los Angeles (UCLA), Health Sciences Why Some Heavy Drinkers Develop Advanced Liver Disease, While Others Do Not /articles/why-some-heavy-drinkers-develop-advanced-liver-disease-while-others-do-not/?sc=c6487 /articles/why-some-heavy-drinkers-develop-advanced-liver-disease-while-others-do-not/?sc=c6487 Thu, 06 Feb 2025 11:00:11 EST Alcohol and Alcoholism,All Journal News,Cardiovascular Health,Diabetes,Healthcare,Liver Disease,Obesity,Top Hit Stories Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2025/02/05/67a3b3ce7903a_AdobeStock236258020.jpeg&width=100&height=150" alt="Newswise image" />A new study from Keck Medicine of USC finds that heavy drinkers with either diabetes, high blood pressure or a high waist circumference are as much as twice as likely to develop advanced liver disease /articles//images/uploads/2025/02/05/67a3b3ce7903a_AdobeStock236258020.jpeg,/images/uploads/2025/02/05/67a3b41e59c78_BrianP.LeeMD.jpg Keck Medicine of USC ACG-ASGE Quality Indicators for Upper GI Endoscopy and More in the February Issue of AJG /articles/acg-asge-quality-indicators-for-upper-gi-endoscopy-and-more-in-the-february-issue-of-ajg/?sc=c6487 /articles/acg-asge-quality-indicators-for-upper-gi-endoscopy-and-more-in-the-february-issue-of-ajg/?sc=c6487 Wed, 05 Feb 2025 08:00:26 EST All Journal News,Digestive Disorders,Healthcare,Liver Disease,Top Hit Stories Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2025/02/04/67a290d232a21_AJGFebruary2025Cover.jpeg&width=100&height=150" alt="Newswise image" />The February issue of The American Journal of Gastroenterology highlights new clinical science and reviews, including joint ACG-ASGE quality indicators for upper GI endoscopy, the first medication for the treatment of at-risk MASH, and a digital gut-directed hypnotherapy program for IBS. /articles//images/uploads/2025/02/04/67a290d232a21_AJGFebruary2025Cover.jpeg American College of Gastroenterology (ACG) Study Sheds Light on Liver Maturation, Specialization /articles/study-sheds-light-on-liver-maturation-specialization/?sc=c6487 /articles/study-sheds-light-on-liver-maturation-specialization/?sc=c6487 Mon, 03 Feb 2025 20:25:31 EST All Journal News,Biotech,Liver Disease,Regenerative Medicine,Stem Cells Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2025/02/03/67a0fd907e439_kalsotralab-250113-FZ-127rfx.JPG&width=100&height=150" alt="Newswise image" />Researchers from the University of Illinois have identified a key process coordinating liver maturation and polyploidization, a state in which cells carry more than two sets of chromosomes. Their findings provide insight into hepatocyte specialization that will aid efforts in regenerative medicine. /articles//images/uploads/2025/02/03/67a0fd907e439_kalsotralab-250113-FZ-127rfx.JPG,/images/uploads/2025/02/03/67a0fda1e19c5_NashandSushant.jpeg,/images/uploads/2025/02/03/67a0fdefc73fb_kalsotralab-250113-FZ-007.JPG College of Liberal Arts and Sciences, University of Illinois Urbana-Champaign How UIC Scientists Redesigned an Effective Cancer Therapy to Make It Safer /articles/how-uic-scientists-redesigned-an-effective-cancer-therapy-to-make-it-safer/?sc=c6487 /articles/how-uic-scientists-redesigned-an-effective-cancer-therapy-to-make-it-safer/?sc=c6487 Fri, 31 Jan 2025 17:10:51 EST All Journal News,Biotech,Blood,Cancer,Children's Health,Healthcare,Liver Disease,Patient Safety Medical News Research Results University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved, the new drug may be tolerated by a broader range of leukemia patients and even be used to treat other cancers. University of Illinois Chicago Children's Hospital Los Angeles has Best Pediatric Liver Transplant Survival Rates in the Country /articles/children-s-hospital-los-angeles-has-best-pediatric-liver-transplant-survival-rates-in-the-country/?sc=c6487 /articles/children-s-hospital-los-angeles-has-best-pediatric-liver-transplant-survival-rates-in-the-country/?sc=c6487 Tue, 28 Jan 2025 09:00:31 EST Artificial Intelligence,Children's Health,Healthcare,Liver Disease,Transplantation Medical News Blog Children's Hospital Los Angeles has the best one-and three-year post-transplant patient and graft survival rates in the nation for pediatric liver transplants, according to newly released 2025 data from the Scientific Registry of Transplant Recipients (SRTR) and the Organ Procurement and Transplant Network (OPTN). Children's Hospital Los Angeles Weight-Loss Surgery Lowers Risk of Developing Complications of Liver Disease in Patients with Cirrhosis and Obesity /articles/weight-loss-surgery-lowers-risk-of-developing-complications-of-liver-disease-in-patients-with-cirrhosis-and-obesity/?sc=c6487 /articles/weight-loss-surgery-lowers-risk-of-developing-complications-of-liver-disease-in-patients-with-cirrhosis-and-obesity/?sc=c6487 Mon, 27 Jan 2025 19:10:48 EST All Journal News,Healthcare,Liver Disease,Nutrition,Obesity,Surgery,Weight Loss,Nature (journal) Medical News Research Results A Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of developing serious liver complications compared with patients who received medical therapy alone. The results were published in Nature Medicine journal. Cleveland Clinic